Developed by Northwestern scientists, a novel skin-mounted sticker that absorbs sweat and then changes color can provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.
Browsing: Clinical Breakthroughs
The largest study to date of neurological manifestations of COVID-19 in children demonstrated patterns in the rare complications seen among pediatric patients.
Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.
Scientists discovered a previously unknown receptor site in a voltage-gated sodium channel, suggesting that a commonly-used cancer drug could be used to target this channel and relieve pain.
Perioperative chemotherapy treatment did not improve overall survival for patients with resectable pancreatic cancer, according to a recent Northwestern Medicine clinical trial.
Working with large, multicenter teams, Northwestern clinician-scientists have examined treatments for blood clotting in critically ill patients with COVID-19, and explored therapies that could reduce disease progression and hospitalization.
Northwestern Medicine investigators have identified a protein kinase called DYRK1A and its downstream substrates as potential therapeutic targets for treating pediatric patients with B-cell acute lymphoblastic leukemia.
A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.
A new anti-obesity medication is almost twice as effective at helping individuals lose weight than current weight-loss drugs, according to a Northwestern Medicine study.
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.